First Bank & Trust’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,847
| Closed | -$57K | – | 264 |
|
|
2022
Q2 | $57K | Sell |
1,847
-254
| -12% | -$7.84K | 0.02% | 277 |
|
|
2022
Q1 | $86K | Buy |
2,101
+251
| +14% | +$10.3K | 0.03% | 264 |
|
|
2021
Q4 | $81K | Buy |
1,850
+452
| +32% | +$19.8K | 0.03% | 251 |
|
|
2021
Q3 | $70K | Hold |
1,398
| – | – | 0.03% | 253 |
|
|
2021
Q2 | $88K | Sell |
1,398
-545
| -28% | -$34.3K | 0.04% | 244 |
|
|
2021
Q1 | $181K | Buy |
1,943
+343
| +21% | +$32K | 0.09% | 170 |
|
|
2020
Q4 | $143K | Sell |
1,600
-669
| -29% | -$59.8K | 0.09% | 168 |
|
|
2020
Q3 | $234K | Sell |
2,269
-786
| -26% | -$81.1K | 0.16% | 118 |
|
|
2020
Q2 | $242K | Buy |
3,055
+1,295
| +74% | +$103K | 0.18% | 110 |
|
|
2020
Q1 | $102K | Buy |
1,760
+711
| +68% | +$41.2K | 0.09% | 164 |
|
|
2019
Q4 | $57K | Buy |
1,049
+962
| +1,106% | +$52.3K | 0.04% | 233 |
|
|
2019
Q3 | $5K | Hold |
87
| – | – | ﹤0.01% | 336 |
|
|
2019
Q2 | $4K | Buy |
+87
| New | +$4K | ﹤0.01% | 334 |
|